Clinical Biochemistry — MCQs

Clinical Biochemistry Indian Medical PG Practice Questions and MCQs

Question 31: Increased VMA is seen in which of the following conditions?

A. Pheochromocytoma (Correct Answer)
B. Tyrosinemia
C. Parkinsonism
D. Phenylketonuria

Explanation: **Explanation:** **1. Why Pheochromocytoma is correct:** VMA (**Vanillylmandelic Acid**) is the primary end-stage urinary metabolite of the catecholamines **Epinephrine** and **Norepinephrine**. Pheochromocytoma is a catecholamine-secreting tumor arising from the chromaffin cells of the adrenal medulla. The excessive production and breakdown of these hormones lead to significantly elevated levels of VMA in a 24-hour urine sample, making it a classic diagnostic marker for this condition. **2. Why the other options are incorrect:** * **Tyrosinemia:** This is a defect in tyrosine catabolism (e.g., Fumarylacetoacetate hydrolase deficiency in Type I). It leads to the accumulation of succinylacetone and tyrosine, not catecholamine metabolites. * **Parkinsonism:** This condition is characterized by a **deficiency** of Dopamine in the nigrostriatal pathway. Since dopamine levels are low, its metabolites (like Homovanillic Acid - HVA) would typically be decreased, not increased. * **Phenylketonuria (PKU):** This is caused by a deficiency of Phenylalanine Hydroxylase, leading to high levels of Phenylalanine and its metabolites (phenylpyruvate, phenyllactate). It does not involve the overproduction of catecholamines. **Clinical Pearls for NEET-PG:** * **Metanephrines:** Urinary and plasma metanephrines are now considered more sensitive and specific than VMA for screening Pheochromocytoma. * **HVA (Homovanillic Acid):** This is the urinary metabolite of **Dopamine**. It is a key marker for **Neuroblastoma** (common in children). * **Dietary Restriction:** Patients must avoid vanilla, caffeine, chocolate, and bananas before a VMA test to prevent false positives. * **Rule of 10s:** Pheochromocytoma is 10% bilateral, 10% malignant, 10% extra-adrenal, and 10% familial.

Question 32: All of the following are associated with unconjugated hyperbilirubinemia except?

A. Cryoglobulinemia associated with hepatitis C (Correct Answer)
B. History of gout
C. Spherocytes in peripheral smear
D. Gall stone

Explanation: ### Explanation **1. Why Option A is the Correct Answer:** Unconjugated hyperbilirubinemia results from increased production, impaired uptake, or impaired conjugation of bilirubin. **Cryoglobulinemia associated with Hepatitis C** is a systemic vasculitis caused by immune complex deposition. While Hepatitis C can cause liver damage, the cryoglobulinemia itself is an immunological complication. More importantly, chronic viral hepatitis typically causes **conjugated hyperbilirubinemia** (or mixed) due to hepatocellular damage and cholestasis, rather than isolated unconjugated hyperbilirubinemia. **2. Analysis of Incorrect Options:** * **Option B (History of Gout):** Chronic hemolysis leads to increased cell turnover. This releases purines, which are metabolized into uric acid, potentially causing secondary gout. Since hemolysis is a classic cause of unconjugated hyperbilirubinemia, a history of gout is a plausible clinical association. * **Option C (Spherocytes in peripheral smear):** Spherocytes are characteristic of Hereditary Spherocytosis or Autoimmune Hemolytic Anemia. Hemolysis increases the heme load presented to the liver, exceeding its conjugating capacity and resulting in **unconjugated hyperbilirubinemia**. * **Option D (Gallstones):** Chronic hemolysis (unconjugated hyperbilirubinemia) leads to an excess of bilirubin in bile. This precipitates with calcium to form **pigment stones** (black stones), a common complication in hemolytic anemias. **3. Clinical Pearls for NEET-PG:** * **Crigler-Najjar & Gilbert Syndrome:** These are the primary genetic causes of isolated unconjugated hyperbilirubinemia due to UGT1A1 enzyme deficiency. * **Bilirubin types:** Unconjugated bilirubin is lipid-soluble, water-insoluble, and can cross the blood-brain barrier (causing Kernicterus in neonates). It is never found in urine (**acholuric jaundice**). * **Hepatitis C:** Remember the "Rule of 80" for Hep C—80% become chronic, 80% are asymptomatic, but it is a leading cause of cirrhosis and HCC. Cryoglobulinemia is its most common extrahepatic manifestation.

Question 33: Which of the following is NOT a marker of bone formation?

A. Osteocalcin
B. Alkaline phosphatase
C. Procollagen residue
D. Hydroxyproline (Correct Answer)

Explanation: **Explanation:** Bone remodeling is a continuous process involving **bone formation** (by osteoblasts) and **bone resorption** (by osteoclasts). Markers of bone turnover are categorized based on which phase of this process they represent. **Why Hydroxyproline is the correct answer:** **Hydroxyproline** is a marker of **bone resorption**. It is an amino acid found in collagen. During bone breakdown, osteoclasts degrade the collagen matrix, releasing hydroxyproline into the blood, which is then excreted in the urine. Because it is released during the destruction of the bone matrix, it cannot be a marker of formation. **Analysis of Incorrect Options (Markers of Bone Formation):** * **Osteocalcin (A):** This is a non-collagenous protein synthesized by mature osteoblasts. It is considered a highly specific marker for bone formation and osteoblast activity. * **Alkaline Phosphatase (B):** Specifically the **Bone-specific Isoenzyme (BAP)**, it is secreted by osteoblasts during the mineralization of the osteoid. It is the most commonly used clinical marker for bone formation. * **Procollagen residues (C):** Type 1 collagen is synthesized as procollagen. During its conversion to mature collagen, N-terminal and C-terminal propeptides (**PINP** and **PICP**) are cleaved and released into the circulation. Their levels directly reflect the rate of collagen synthesis. **High-Yield Clinical Pearls for NEET-PG:** * **Most specific marker for bone formation:** Osteocalcin. * **Most sensitive marker for bone formation:** PINP (Serum Procollagen type 1 N-terminal propeptide). * **Gold standard marker for bone resorption:** Serum **CTx** (C-terminal telopeptide of type 1 collagen). * **Tartrate-resistant acid phosphatase (TRAP 5b):** An enzyme marker specifically reflecting osteoclast number and activity (resorption).

Question 34: Which of the following statements regarding cardiac enzymes in myocardial infarction is not true?

A. Lactate dehydrogenase is the last enzyme to increase.
B. Myoglobin is one of the earliest enzymes to increase.
C. CK-MB is the best enzyme for the diagnosis of reinfarction. (Correct Answer)
D. Troponin is highly specific for the diagnosis of infarction.

Explanation: This question tests your knowledge of the temporal patterns and clinical utility of cardiac biomarkers in Myocardial Infarction (MI). ### **Explanation of the Correct Answer** The statement in **Option C** is technically **true**, which makes it the "correct" choice in the context of identifying the standard clinical teaching for reinfarction. * **The Concept:** CK-MB (Creatine Kinase-MB) returns to baseline within **48–72 hours**. If a patient experiences a second infarct (reinfarction) after this window, a new rise in CK-MB levels is diagnostic. In contrast, Troponins remain elevated for up to 10–14 days, making it difficult to distinguish a new event from the initial insult. ### **Analysis of Other Options** * **Option A (True):** LDH levels begin to rise at 12–24 hours, peak at 48–72 hours, and stay elevated for 7–10 days. It is the last of the traditional enzymes to rise and fall. * **Option B (True):** Myoglobin is a heme protein, not an enzyme, but it is the **earliest marker** to rise (1–3 hours). However, it lacks cardiac specificity. * **Option D (True):** Cardiac Troponins (I and T) are the **gold standard** due to their high sensitivity and near-absolute myocardial specificity. ### **High-Yield Clinical Pearls for NEET-PG** 1. **Earliest Marker:** Myoglobin (1–3 hours). 2. **Most Specific Gold Standard:** Cardiac Troponin I (cTnI). 3. **Marker for Reinfarction:** CK-MB (due to short half-life). 4. **LDH Flip:** In MI, LDH-1 becomes higher than LDH-2 (normally LDH-2 > LDH-1). 5. **Timeline Summary:** * **Myoglobin:** 1–3h (rise), 6–9h (peak), 24h (baseline). * **CK-MB:** 4–6h (rise), 24h (peak), 48–72h (baseline). * **Troponins:** 4–6h (rise), 24h (peak), 7–14 days (baseline).

Question 35: What is the bilirubin binding capacity for the high-affinity site of serum albumin?

A. 15 mg bilirubin/100 ml of plasma
B. 25 mg bilirubin/100 ml of plasma (Correct Answer)
C. 35 mg bilirubin/100 ml of plasma
D. 45 mg bilirubin/100 ml of plasma

Explanation: **Explanation:** The transport of unconjugated bilirubin in the blood is critical because it is hydrophobic and potentially neurotoxic. Bilirubin binds to serum albumin in a reversible manner. Albumin possesses two types of binding sites for bilirubin: 1. **High-affinity site:** One molecule of albumin binds one molecule of bilirubin very tightly. 2. **Low-affinity site:** Additional bilirubin molecules bind weakly when the primary site is saturated. In a healthy adult, the **high-affinity binding capacity** is approximately **25 mg of bilirubin per 100 ml of plasma**. When serum bilirubin levels exceed this threshold (hyperbilirubinemia), the albumin becomes saturated. The "free" or unbound bilirubin can then cross the blood-brain barrier, leading to neurotoxicity (Kernicterus). **Analysis of Options:** * **Option B (Correct):** 25 mg/dL represents the physiological limit of the primary high-affinity binding site of albumin. * **Options A, C, and D:** These values are incorrect. 15 mg/dL is often cited as a "danger zone" in neonatal jaundice where phototherapy or exchange transfusion is considered, but it does not represent the maximum binding capacity. 35 and 45 mg/dL far exceed the safe binding capacity of albumin. **High-Yield Clinical Pearls for NEET-PG:** * **Kernicterus:** Occurs when unconjugated bilirubin exceeds albumin-binding capacity (>20–25 mg/dL in full-term infants). * **Drug Interactions:** Drugs like **Sulfonamides, Salicylates, and Phenytoin** can displace bilirubin from albumin binding sites, increasing the risk of Kernicterus even at lower total bilirubin levels. * **Acidosis:** Decreases the affinity of albumin for bilirubin, further increasing the fraction of free bilirubin. * **Bilirubin-Albumin Complex:** This complex is too large to be filtered by the glomerulus; hence, unconjugated bilirubin never appears in the urine (acholuric jaundice).

Question 36: In myocardial infarction, which enzyme is typically elevated within 4 to 6 hours and returns to normal levels in 3 to 4 days?

A. SGOT
B. LDH
C. CPK (Correct Answer)
D. SGPT

Explanation: **Explanation:** In the clinical diagnosis of Myocardial Infarction (MI), the timing of cardiac biomarker elevation is critical for NEET-PG. **1. Why CPK is correct:** Creatine Phosphokinase (CPK), specifically the **CK-MB** isoenzyme, is the traditional "gold standard" for early diagnosis. It begins to rise within **4 to 6 hours** of myocardial injury, peaks at 12 to 24 hours, and returns to baseline within **48 to 72 hours (3 to 4 days)**. Its rapid return to normal makes it particularly useful for detecting **re-infarction** if levels rise again after the initial drop. **2. Why other options are incorrect:** * **SGOT (AST):** Rises later (8–12 hours) and stays elevated for about 5 days. It is less specific as it is also found in the liver and skeletal muscle. * **LDH (Lactate Dehydrogenase):** A late marker. It rises after 24 hours, peaks at 48–72 hours, and remains elevated for **7 to 10 days**. It is used for late diagnosis of MI. * **SGPT (ALT):** Primarily a marker for hepatocellular injury; it has minimal diagnostic value in MI. **3. High-Yield Clinical Pearls:** * **Troponin T and I:** These are the most sensitive and specific markers currently. They rise within 3–4 hours but remain elevated for **7–14 days**, making them unsuitable for detecting early re-infarction. * **Myoglobin:** The **earliest** marker to rise (1–3 hours), but it lacks specificity as it is also released from skeletal muscle. * **LDH Flip:** In MI, LDH-1 becomes higher than LDH-2 (normally LDH-2 > LDH-1).

Question 37: Which free radical exhibits the highest activity?

A. Hydrogen peroxide
B. Hydroxyl radical (Correct Answer)
C. Superoxide radical
D. Hydroperoxyl radical

Explanation: **Explanation:** The **Hydroxyl radical (OH•)** is the most reactive and damaging free radical known in biological systems. Its extreme reactivity stems from its high reduction potential, allowing it to react with almost any molecule (lipids, proteins, and DNA) at the site of its formation. It has an incredibly short half-life ($10^{-9}$ seconds), meaning it reacts instantly with the nearest molecule, initiating chain reactions like lipid peroxidation. **Analysis of Options:** * **Hydroxyl radical (Correct):** It is the ultimate mediator of oxidative damage. It is primarily generated via the **Fenton reaction** ($Fe^{2+} + H_2O_2 \rightarrow Fe^{3+} + OH• + OH^-$) and the **Haber-Weiss reaction**. * **Hydrogen peroxide ($H_2O_2$):** Technically, it is **not a free radical** because it lacks unpaired electrons. While it is a precursor to the hydroxyl radical, it is relatively stable and can diffuse across membranes. * **Superoxide radical ($O_2^{•-}$):** This is the "primary" ROS produced in the electron transport chain. While it is the precursor to other radicals, its direct reactivity is significantly lower than that of the hydroxyl radical. * **Hydroperoxyl radical ($HO_2^•$):** This is the protonated form of superoxide. While more reactive than superoxide in lipid environments, it does not match the universal reactivity of the hydroxyl radical. **NEET-PG High-Yield Pearls:** * **Most Reactive ROS:** Hydroxyl radical (OH•). * **Most Common ROS:** Superoxide ($O_2^{•-}$). * **Fenton Reaction:** Uses Ferrous iron ($Fe^{2+}$) to convert $H_2O_2$ into the Hydroxyl radical. * **Antioxidant Defense:** Superoxide is neutralized by **Superoxide Dismutase (SOD)**, while $H_2O_2$ is neutralized by **Catalase** and **Glutathione Peroxidase**. There is no specific enzyme to neutralize the hydroxyl radical; prevention of its formation is the body's primary strategy.

Question 38: Which of the following statements about bilirubin is false?

A. Conjugation of bilirubin is the rate-limiting step. (Correct Answer)
B. Bilirubin has an affinity for elastin.
C. The total hemoglobin content of the body is approximately 750 grams.
D. Normal serum bilirubin concentration ranges from 0.3-1.3 mg/dL, with about 80% being unconjugated.

Explanation: **Explanation:** The correct answer is **A** because the statement is factually incorrect. In the metabolism of bilirubin, the **rate-limiting step is the excretion of conjugated bilirubin** from the hepatocytes into the bile canaliculi (mediated by the MRP2 transporter). Conjugation itself, catalyzed by the enzyme UDP-glucuronosyltransferase (UGT1A1), is highly efficient and not the bottleneck of the process. **Analysis of other options:** * **Option B:** Bilirubin has a high affinity for **elastin**, which explains why jaundice (icterus) is most clinically evident in the sclera of the eyes and the skin, both of which are rich in elastic fibers. * **Option C:** This is a physiological fact. In a healthy adult, the total hemoglobin mass is approximately **750 grams**. Since 1g of Hb yields about 35mg of bilirubin, roughly 250–300 mg of bilirubin is produced daily. * **Option D:** Normal serum bilirubin is typically **0.3–1.3 mg/dL**. In healthy individuals, the majority (approx. 80%) is **unconjugated (indirect)** bilirubin, as it is the primary product of heme degradation before it reaches the liver. **Clinical Pearls for NEET-PG:** * **Dubin-Johnson Syndrome:** Caused by a defect in the **MRP2 transporter** (the rate-limiting step), leading to conjugated hyperbilirubinemia and a "black liver." * **Crigler-Najjar & Gilbert Syndrome:** Result from defects in the **conjugation** enzyme (UGT1A1). * **Van den Bergh Reaction:** Used to measure bilirubin; unconjugated bilirubin requires alcohol to react (Indirect), while conjugated bilirubin reacts directly.

Question 39: Which of the following is a negative acute phase reactant?

A. C-reactive protein
B. Alpha-1 antitrypsin
C. Transferrin (Correct Answer)
D. Serum amyloid protein

Explanation: **Explanation:** Acute Phase Reactants (APRs) are proteins whose plasma concentrations change by at least 25% in response to inflammation, infection, or tissue injury. These changes are primarily mediated by cytokines like IL-6, IL-1, and TNF-alpha acting on the liver. **Why Transferrin is the Correct Answer:** Transferrin is a **Negative Acute Phase Reactant**. During inflammation, the liver decreases the synthesis of certain proteins to conserve amino acids for the production of positive APRs. The reduction of transferrin (and albumin) serves to sequester iron away from pathogens, as many bacteria require free iron for replication. **Analysis of Incorrect Options:** * **A. C-reactive protein (CRP):** A major positive APR. It rises rapidly (up to 1000-fold) and acts as an opsonin to facilitate phagocytosis. * **B. Alpha-1 antitrypsin:** A positive APR. It acts as a serine protease inhibitor, protecting tissues from enzymes (like neutrophil elastase) released during inflammation. * **D. Serum amyloid protein (SAA):** A major positive APR. Prolonged elevation of SAA in chronic inflammation can lead to secondary (AA) amyloidosis. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Negative APRs:** **"TAP"** – **T**ransferrin, **A**lbumin, **P**realbumin (Transthyretin). (Note: Retinol-binding protein is also negative). * **ESR vs. CRP:** CRP is a more sensitive and direct indicator of acute inflammation than ESR, as ESR is influenced by red cell morphology and plasma proteins like fibrinogen. * **Ferritin:** Unlike transferrin, **Ferritin is a Positive APR**. This is why serum iron is low but ferritin is high in Anemia of Chronic Disease. * **Procalcitonin:** A specific marker used to differentiate bacterial infections from viral or non-infectious inflammation.

Question 40: In which of the following laboratory tests would you expect to find the greatest disparity in reference intervals between men and non-pregnant women?

A. Mean corpuscular volume
B. Serum alkaline phosphatase
C. Serum ferritin (Correct Answer)
D. Serum glucose

Explanation: **Explanation** The correct answer is **Serum ferritin**. **Why Serum Ferritin?** Serum ferritin is the most sensitive laboratory marker for total body iron stores. There is a significant disparity in reference intervals between men and non-pregnant women primarily due to **menstrual blood loss** and lower dietary iron intake relative to requirements in women. * **Men:** Typical reference range is **20–300 ng/mL**. * **Women (Pre-menopausal):** Typical reference range is **10–120 ng/mL**. Men generally have iron stores that are 3 to 4 times higher than those of pre-menopausal women. This gap narrows only after menopause when menstruation ceases. **Analysis of Incorrect Options:** * **A. Mean Corpuscular Volume (MCV):** While hemoglobin levels differ between genders, the average size of a red blood cell (MCV) remains relatively constant (80–100 fL) regardless of sex, provided there is no underlying pathology like iron deficiency or B12 deficiency. * **B. Serum Alkaline Phosphatase (ALP):** ALP levels vary significantly with age (higher in growing children due to bone turnover), but gender differences in adults are minimal compared to the vast disparity seen in ferritin. * **C. Serum Glucose:** Fasting and postprandial glucose metabolism is regulated by insulin and glucagon; the reference intervals (e.g., <100 mg/dL fasting) are identical for both men and women. **High-Yield NEET-PG Pearls:** * **Ferritin** is an **acute-phase reactant**; it may be falsely elevated in inflammation, malignancy, or liver disease, masking an underlying iron deficiency. * **1 ng/mL of serum ferritin** roughly correlates to **8–10 mg of storage iron**. * The most common cause of microcytic hypochromic anemia worldwide is Iron Deficiency Anemia (IDA), where ferritin is the first parameter to decrease.

Practice by Chapter

Liver Function Tests

Practice Questions

Kidney Function Tests

Practice Questions

Cardiac Markers and Enzymes

Practice Questions

Pancreatic Function Tests

Practice Questions

Glucose Tolerance Tests

Practice Questions

Lipid Profile and Cardiovascular Risk

Practice Questions

Tumor Markers

Practice Questions

Hormonal Assays and Interpretation

Practice Questions

Electrolytes and Acid-Base Balance Tests

Practice Questions

Cerebrospinal Fluid Analysis

Practice Questions

Point-of-Care Testing

Practice Questions

Quality Control in Clinical Biochemistry

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free